Overview

Perineural Injection Therapy for Ulnar Neuropathy at Elbow

Status:
Completed
Trial end date:
2019-10-30
Target enrollment:
0
Participant gender:
All
Summary
Ulnar neuropathy at elbow (UNE) is the second common peripheral entrapment neuropathy. Although many conservative managements of UNE, the effectiveness of these methods are unsatisfied especial the moderate degree of UNE. Recently, ultrasound-guided perineural injection therapy (PIT) with 5% dextrose is progressively applicated for clinical treatment for entrapment neuropathy. However, current studies have not proved the effects of PIT on peripheral neuropathy because these studies enrolled small number of patients and lacked controlled design. We design a randomized, double-blind, controlled trail to assess the effect after ultrasound-guided PIT with 5% dextrose in patients with mild and moderate UNE.
Phase:
N/A
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Tri-Service General Hospital
Treatments:
Lidocaine
Triamcinolone
Triamcinolone Acetonide
Triamcinolone diacetate
Triamcinolone hexacetonide
Criteria
Inclusion Criteria:

- Age between 20-80 year-old.

- Diagnosis was confirmed using an electrophysiological study

Exclusion Criteria:

- Cancer

- Coagulopathy

- Pregnancy

- Inflammation status

- Cervical radiculopathy

- Polyneuropathy, brachial plexopathy

- Thoracic outlet syndrome

- Previously undergone wrist surgery or steroid injection for ulnar neuropathy